After several rounds of treatment for a rare eye cancer—weekly drug infusions that could cost nearly $50,000 each—Paul Davis learned Medicare had abruptly stopped paying the bills.
That left Davis, a retired physician in Findlay, Ohio, contemplating a horrific choice: risk saddling his family with huge medical debt—if he has to pay those bills from the hospital out-of-pocket—or halt treatments that help keep him alive.
